# Non-inferiority of PRO-122 Ophthalmic Solution vs KRYTANTEK Ofteno® in Glaucoma or Ocular Hypertension (CONFORTK)

> **NCT03257813** · PHASE3 · COMPLETED · sponsor: **Laboratorios Sophia S.A de C.V.** · enrollment: 60 (actual)

## Conditions studied

- Primary Open Angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** PRO-122
- **DRUG:** Krytantek Ofteno®

## Key facts

- **NCT ID:** NCT03257813
- **Lead sponsor:** Laboratorios Sophia S.A de C.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-01
- **Primary completion:** 2017-03-01
- **Final completion:** 2017-06-18
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2019-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03257813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03257813, "Non-inferiority of PRO-122 Ophthalmic Solution vs KRYTANTEK Ofteno® in Glaucoma or Ocular Hypertension (CONFORTK)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03257813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*